William Blair Brokers Decrease Earnings Estimates for PIII

P3 Health Partners Inc. (NASDAQ:PIII) – Equities research analysts at William Blair reduced their FY2024 earnings per share estimates for P3 Health Partners in a report issued on Wednesday, November 13th. William Blair analyst R. Daniels now forecasts that the company will earn ($0.67) per share for the year, down from their prior estimate of ($0.23). The consensus estimate for P3 Health Partners’ current full-year earnings is ($0.67) per share. William Blair also issued estimates for P3 Health Partners’ Q4 2024 earnings at ($0.17) EPS, Q1 2025 earnings at ($0.11) EPS, Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.42) EPS.

P3 Health Partners Price Performance

Shares of PIII opened at $0.21 on Monday. The stock has a market cap of $75.94 million, a P/E ratio of -0.25 and a beta of 1.15. P3 Health Partners has a 1 year low of $0.20 and a 1 year high of $1.78. The stock’s 50-day moving average price is $0.39 and its two-hundred day moving average price is $0.50. The company has a current ratio of 0.53, a quick ratio of 0.69 and a debt-to-equity ratio of 1.11.

Institutional Trading of P3 Health Partners

Several hedge funds have recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its stake in P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after acquiring an additional 550,925 shares during the period. Armistice Capital LLC bought a new position in shares of P3 Health Partners during the 2nd quarter valued at about $3,557,000. Renaissance Technologies LLC grew its position in shares of P3 Health Partners by 188.1% in the 2nd quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock valued at $50,000 after purchasing an additional 73,000 shares during the period. Emfo LLC increased its stake in P3 Health Partners by 39.8% during the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock worth $643,000 after purchasing an additional 406,418 shares in the last quarter. Finally, Sanders Morris Harris LLC raised its holdings in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock worth $64,000 after buying an additional 20,000 shares during the period. Institutional investors and hedge funds own 7.75% of the company’s stock.

Insider Activity at P3 Health Partners

In other news, major shareholder Pacific Founders Ugp I. Chicago purchased 80,000 shares of the firm’s stock in a transaction dated Friday, September 6th. The stock was bought at an average price of $0.49 per share, with a total value of $39,200.00. Following the acquisition, the insider now directly owns 76,785,438 shares of the company’s stock, valued at approximately $37,624,864.62. This represents a 0.10 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have bought 400,000 shares of company stock worth $205,600 in the last ninety days. Company insiders own 17.86% of the company’s stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.